Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Dawson, Sarah"'
Autor:
Lee JH; Department of Biomedical Science, Macquarie University, Sydney, New South Wales, Australia. jenny.lee@mq.edu.au.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Medical Oncology, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney University Medical School, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia., Carlino MS; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney University Medical School, Sydney, New South Wales, Australia.; Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney, New South Wales, Australia., McEvoy AC; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Weppler AM; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Diefenbach RJ; Department of Biomedical Science, Macquarie University, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Melbourne, Victoria, Australia., Kefford RF; Department of Biomedical Science, Macquarie University, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia., Millward MJ; School of Medicine, University of Western Australia, Perth, Western Australia, Australia.; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia., Al-Ogaili Z; Department of Molecular Imaging and Therapy Service, Fiona Stanley Hospital, Perth, Western Australia, Australia., Tra T; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Gray ES; School of Medical and Health Sciences, Edith Cowan University, Perth, Western Australia, Australia., Wong SQ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Scolyer RA; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Department of Pathology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.; Sydney University Medical School, Sydney, New South Wales, Australia.; Department of Medical Oncology, Royal North Shore Hospital, Sydney, Australia.; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia., Rizos H; Department of Biomedical Science, Macquarie University, Sydney, New South Wales, Australia.; Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 01; Vol. 26 (15), pp. 4064-4071. Date of Electronic Publication: 2020 Apr 22.
Autor:
Dawson SJ; Divisions of Cancer Medicine and Research, Peter MacCallum Cancer Centre, Melbourne 3000, Australia; Centre for Cancer Research, University of Melbourne, Melbourne 3010, Australia.
Publikováno v:
Cold Spring Harbor perspectives in medicine [Cold Spring Harb Perspect Med] 2019 Apr 01; Vol. 9 (4). Date of Electronic Publication: 2019 Apr 01.
Autor:
Stewart CM; Marie-José and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Kothari PD; Marie-José and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pediatric Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mouliere F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cancer Research UK Major Centre - Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK., Mair R; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.; Cancer Research UK Major Centre - Cambridge, Cancer Research UK Cambridge Institute, Cambridge, UK.; Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, UK., Somnay S; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Benayed R; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Zehir A; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Weigelt B; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Dawson SJ; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria, Australia.; Centre for Cancer Research, University of Melbourne, Victoria, Australia., Arcila ME; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Berger MF; Marie-José and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tsui DW; Marie-José and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The Journal of pathology [J Pathol] 2018 Apr; Vol. 244 (5), pp. 616-627. Date of Electronic Publication: 2018 Mar 12.
Autor:
Stewart, Caitlin M, Kothari, Prachi D, Mouliere, Florent, Mair, Richard, Somnay, Saira, Benayed, Ryma, Zehir, Ahmet, Weigelt, Britta, Dawson, Sarah-Jane, Arcila, Maria E, Berger, Michael F, Tsui, Dana Wy
Publikováno v:
Stewart, C M, Kothari, P D, Mouliere, F, Mair, R, Somnay, S, Benayed, R, Zehir, A, Weigelt, B, Dawson, S J, Arcila, M E, Berger, M F & Tsui, D W Y 2018, ' The value of cell-free DNA for molecular pathology ', Journal of Pathology, vol. 244, no. 5, pp. 616-627 . https://doi.org/10.1002/path.5048
Over the past decade, advances in molecular biology and genomics techniques have revolutionized the diagnosis and treatment of cancer. The technological advances in tissue profiling have also been applied to the study of cell-free nucleic acids, an a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1864715630b9682b6b65b1a01d62305e
https://research.vumc.nl/en/publications/1933d322-8d53-4f8b-9cdf-c820123c84a9
https://research.vumc.nl/en/publications/1933d322-8d53-4f8b-9cdf-c820123c84a9